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Modeling and simulation in computational neuroscience is currently a research
enterprise to better understand neural systems. It is not yet directly applicable to the
problems of patients with brain disease. To be used for clinical applications, there
must not only be considerable progress in the field but also a concerted effort to
use best practices in order to demonstrate model credibility to regulatory bodies, to
clinics and hospitals, to doctors, and to patients. In doing this for neuroscience, we
can learn lessons from long-standing practices in other areas of simulation (aircraft,
computer chips), from software engineering, and from other biomedical disciplines.
In this manuscript, we introduce some basic concepts that will be important in the
development of credible clinical neuroscience models: reproducibility and replicability;
verification and validation; model configuration; and procedures and processes for
credible mechanistic multiscale modeling. We also discuss how garnering strong
community involvement can promote model credibility. Finally, in addition to direct usage
with patients, we note the potential for simulation usage in the area of Simulation-Based
Medical Education, an area which to date has been primarily reliant on physical models
(mannequins) and scenario-based simulations rather than on numerical simulations.
Keywords: computational neuroscience, verification and validation, model sharing, modeling and simulations,
Simulation-Based Medical Education, multiscale modeling, personalized and precision medicine, mechanistic
modeling
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INTRODUCTION
One hallmark of science is reproducibility. An experiment that
cannot be reproduced by others may result from statistical
aberration, artifact, or fraud. Such an experiment is not credible.
Therefore, reproducibility is the first stage to ensure the
credibility of an experiment. However, reproducibility alone is
not sufficient. For example, an in vitro experiment is performed to
advance or aid the understanding of in vivo conditions. However,
the applicability of in vitro results to the living tissue may be
limited due to the artifact of isolation: a single cell or a tissue slice
extracted from its environment will not function in precisely the
way it functioned in situ. In medicine, animal models of a disease
or treatment are frequently used, but may not be credible due to
the many differences between the human and the monkey, rat, or
another animal that may limit the transfer of findings from one
species to another.
In the computational world, the credibility of a simulation,
model or theory depends strongly on the projected model
use. This is particularly true when translating a model from
research usage to clinical usage. In research, innovation and
exploration are desirable. Computer models are used to introduce
or explore new hypotheses, ideally providing a new paradigm for
experimentation. In this setting, the most important models may
in some cases be the less credible ones – these are the models that
stretch understanding by challenging the common view of how a
particular system works, in order to offer a paradigm shift. Here,
prima facie credibility is in the eye of the beholder, who is more
likely representing the views of the community – the dominant
paradigm.
In the clinical realm, by contrast, establishing credibility is
of paramount importance. For pharmaceuticals, credibility is
currently established through evidence-based medicine (EBM),
ideally through double-blind trials with large numbers of
patients. The downside of this statistical approach is that it
necessarily aggregates a large number of disparate patients to
achieve statistical significance. In some cases, this has resulted
in tragedy, as a subgroup with particular genetics has a fatal
response to a drug that is beneficial in the overall group (e.g.,
rofecoxib, brand-name Vioxx). As EBM gives way to precision
medicine, pharmaceutical credibility will be established in each
subgroup, or even at an individual level, to enhance safety.
However, to establish pharmaceutical reliability for personalized
medicine (precision with a subgroup of n = 1), a lack of
comparator precludes the use of data-mining by definition.
Simulations based on patient genetics and various levels of
epigenetics up through brain connectomics will then be the only
way to predict the response of an individual patient to a particular
treatment. Such patient simulation would provide a prediction of
the response of that patient’s unique physiodynamics to a therapy.
The credibility of such models will be essential.
In addition to pharmacotherapy, brain disease treatment also
utilizes other therapeutic modalities, ranging from neurosurgery
to the talk therapy of psychiatry and clinical psychology.
While the latter will likely remain beyond the range of our
modeling efforts, neurosurgery has already begun to benefit
from modeling efforts to identify locations and pathways for
epilepsy ablation surgery (Jirsa et al., 2017; Lytton, 2017; Proix
et al., 2017). Another set of therapeutic approaches that are
likely to benefit from modeling are the electrostimulation
therapies that are finding increased use in both neurology
and psychiatry, e.g., deep brain stimulation (DBS), transcranial
magnetic stimulation (TMS), transcranial direct/alternating
current stimulation (tDCS/tACS), and electroconvulsive therapy
(ECT) (Kellner, 2012). Neurorehabilitation will also benefit
from modeling to help identify procedures to encourage
neuroplasticity at locations where change will have the greatest
effect for relief of deficit.
In most respects, the issues of credibility, replicability,
reproducibility for computational neuroscience simulation are
comparable to those faced by researchers using simulation to
study other organ systems. However, the complexity of the
brain and several special features provide unique challenges.
As with modeling of other organ systems, the relevant length
scales range from molecular (angstrom) level up through tissue
(centimeter) levels. Many experiments extend from the lowest to
highest scales, for example evaluating performance on a memory
task as a drug modifies ion channel activity at the molecular
level. Compared to other organ systems, there is a particularly
broad range of temporal scales of interest: 100 microseconds of
sodium channel activation up to years of brain maturation and
learning. In addition to physical scales of the central nervous
system (CNS) itself, brain research includes further investigative
levels of cognition, information, and behavior. An additional
aspect of nervous system organization involves overlap between
scales, which prevents encapsulation of one scale for inclusion in
the higher scale. For example, spatiotemporal activity in apical
dendrites of neocortical pyramidal cells (subcellular level) are co-
extensive in both spatial and temporal scales with the scales of the
local network (supracellular level).
In this paper, we will focus on the many issues of model
credibility from a biomedical and clinical perspective. We will
use model here forward to mean a mathematical model, primarily
analyzed in silico via a simulation, which is the numerical
instantiation of a mathematical model on a computer. We will
identify explicitly in cases where we are discussing other types
of models: verbal models, animal models, physical models, etc.
Currently, there are still relatively few models of brain disease,
and those remain in the research domain, rather than being
practical clinical tools. Therefore, we are considering policy and
practice for a future clinical computational neuroscience, based
on the current uses of computational neuroscience in basic
biomedical research, and on the clinical usage of simulations
in other domains of medicine. In doing this, we will introduce
some basic concepts that are important in the development of
credible models: Reproducibility and Replicability; Verification
and Validation.
REPRODUCIBILITY AND REPLICABILITY
Replicability, here subsuming repeatability, is the ability to
achieve a fully identical result (Plesser, 2017). For example, in
the case of neuronal network simulation, a simulation has been
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fully replicated when one can show that spike times, as well as
all state variables (voltages, calcium levels), are identical to those
in the original simulation. Replicability is a design desideratum
in engineering when one wants to ensure that a system being
distributed runs identically to a prototype system (Drummond,
2009; Crook et al., 2013; McDougal et al., 2016a).
Reproducibility, in contrast, is the ability of a simulation to be
copied by others to provide a simulation that provides the same
results (Crook et al., 2013; McDougal et al., 2016a). This will then
depend on what one considers to be a result, which will reflect the
purposes of the simulation and will involve some measures taken
on the output. Taking again the case of the neuronal network
simulation, a result might involve some direct statistical measures
of spiking (e.g., population rates), perhaps complemented by
the summary statistics provided by field potential spectra, likely
ignoring state-variable trajectories or their statistics.
Replicability and reproducibility are inversely related.
A turnkey system, provided on dedicated hardware or a
dedicated virtual machine, will run identically every time
and therefore be fully replicable. However, such a system
will not be reproducible by outsiders, and may in some
cases have been encrypted to make it difficult to reverse
engineer. Generally, the higher level the representation is,
the more readily other groups understand a simulation and
reproduce the results, but the less likely it is that they obtain
an identical result – lower replicability. Representations using
equations – algebra, linear algebra, calculus – are identical
worldwide and therefore can provide the greatest degree of
reproducibility by any group anywhere. However, reproducing a
simulation from equations is a laborious process, more difficult
than reproducing from algorithms, which is, in turn, more
laborious than reproducing from a declarative (e.g., XML)
representation. A dedicated package in the domain which
provides a declarative description of a simulation will be more
easily ported than general mathematical declarative description
for \dynamical systems. Even at the level of reproduction from
software code, differences in numerical algorithms used in
computer implementations will lead to somewhat different
results.
Different software representations also provide different levels
of difficulty in the task of reproducing a simulation by porting to
another language. The major innovation in this respects has been
the development and adoption of object-oriented languages such
as Java and Python. In particular, the use of object inheritance
allows the definition of a type (e.g., a cell) with a subsequent
definition of particular subtypes, where each type has parameter
differences that are easily found and can be clearly documented
by provenance.
Some difficulties with precise replicability of simulations are
common to many different simulation systems. In particular,
a model that uses pseudo-random numbers will not replicate
precisely if a different randomizer is used, if seeds are not
provided, or if randomizers are not handled properly when going
from serial to parallel implementations. One difficulty peculiar
to neural simulation is related to the strong non-linearities
(and numerical stiffness) associated with action potential spike
thresholding. Spiking networks are sensitive to round-off error; a
single time-step change in spike time will propagate to produce
changes in the rest of the network (London et al., 2010).
In general, specific simulation programs have enhanced
reproducibility by providing purpose-built software to solve the
particular problems of the computational neuroscience domain.
Typically, these packages couple ordinary differential equation
(ODE) solvers for simulating individual neurons with an event-
driven queuing system to manage spike event transmission to
other neurons in neuronal networks. These facilities are provided
by neuronal network simulators such as BRIAN (Goodman and
Brette, 2008), PyNN (Davison et al., 2008), and NEST (Plesser
et al., 2015), which allow spiking neurons to be connected in
networks of varying size. It should be noted that these simulators
are very different from the artificial neural networks used in
deep learning, which do not implement spiking neurons. Some
other packages also add the ability to do more detailed cellular
simulation for the individual neurons by adding the partial
differential equations (PDE) needed to simulate the internal
chemophysiology that complements the electrophysiology of
spiking – NEURON (Carnevale and Hines, 2006) and MOOSE
(Dudani et al., 2009) provide this additional functionality. Many
computational neuroscience simulations in are still carried out
using general-purpose mathematical software, e.g., Matlab (The
Mathworks, Inc., Natick, MA, United States); or by more general
computer languages such as FORTRAN, C, or C++, limiting
their reproducibility, reusability, and extensibility. However, it
should also be noted that the popularity of software also plays
a role. A language or package that is widely used will increase
the number of people that can easily contribute to developing or
utilizing the simulations.
Since computational neuroscience simulations are often
very large, extensibility to high-performance computing (HPC)
resources is also desirable and will enhance reproducibility.
Some current simulator tools offer a direct path to these larger
machines. NetPyNE, a declarative language built on top of
NEURON, provides a general description of a network that
can be run directly either on a serial processor or, via MPI
(message passing interface), on an HPC resource (Lytton et al.,
2016). The Neuroscience Gateway Portal provides a shared, NSF-
supported graphical resource that simplifies HPC for a variety
of simulators, including NetPyNE, NEURON, NEST, BRIAN,
and others, avoiding the need for the user to know MPI usage
(Carnevale et al., 2014).
Hypothetically, journal articles permit reproducibility using
equations given in the Methods section. Often, however, full
details are not provided due to the enormous complexity
of information associated with many different cell types,
and complex network connectivity (McDougal et al., 2016a).
Furthermore, parameters and equations may be given for one
figure, but not for all figures shown. Journal articles may also
have typographical or omission errors. And even when the
document is complete and entirely without error, errors are likely
to creep in when reproduction is attempted, and the model is
typed or scanned back into a computer. For all of these reasons,
an electronic version of a model is more accurate and more
immediately usable than a paper copy. Some journals, and many
individual editors or reviewers, require software sharing as part
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of the publication process. However, some authors resist this
mandate, desiring to retain exclusive access to their intellectual
property.
Databases of models and parts of models have become
important and have encouraged reproducibility in computational
neuroscience (Gleeson et al., 2017). Additional value is added
by utilizing formal model definitions such as ModelML,
CellML, NeuroML, VCML, SBML (Hucka et al., 2003; Zhang
et al., 2007; Lloyd et al., 2008; Moraru et al., 2008; Gleeson
et al., 2010; Cannon et al., 2014). Major databases are being
provided by the Human Brain Project, the Allen Brain Institute,
the International Neuroinformatics Coordinating Facility,
and others. Other databases include the NeuroMorpho.Org
database of neuronal morphologies, the ModelDB database of
computational neuroscience models (see this issue) in a variety
of simulation packages and languages, and the Open Source
Brain database for collaborative research (Gleeson et al., 2012,
2015; Gleeson et al., unpublished). We discuss these resources
further in the section discussing the “Role of the Community.”
A recent initiative to encourage reproducibility in science is
the new ReScience Journal (rescience.github.io), which publishes
papers that replicate prior computational studies. By hosting the
journal on GitHub, new implementations are directly available
alongside the paper, and alongside any ancillary materials
identifying provenance or providing documentation. Recently,
the classic Potjans-Diesmann cortical microcircuit model was
ported from NEST to BRIAN, reproducing and confirming the
primary results (Cordeiro et al., unpublished).
GOOD PRACTICES CONTRIBUTING TO
SIMULATION CREDIBILITY
Verification and Validation (V&V)
Verification
Verification and validation (V&V) help users demonstrate the
credibility of a computational model within the context of its
intended use. This is accomplished by assessing the quantitative
and qualitative aspects of the model that influence model
credibility. The process of establishing the model’s correctness
and its capability to represent the real system is accomplished
through the processes of verification, validation, uncertainty
propagation, and sensitivity analysis. Of these, V&V represent
the most well-known, and potentially confused, aspects of model
assessment.
Computational models may be implemented using open-
source or commercial (off-the-shelf) software, custom (in-house)
code, or a combination of the two (modified off-the-shelf
software). Verification assures that a computational model
accurately represents the underlying mathematical equations
and their solution on a specific code platform. Verification
also emphasizes confirmation of parameter specification
and the accurate translation of model data from model
data sources into the model application. Full verification
for all possible inputs is technically not possible due to
the halting problem. Nonetheless, software implementation
of model concepts should always include some level of
code verification and, to the extent possible, follow best
management practices and established quality-assurance
processes. In the case of commonly used simulation packages,
verification will be the responsibility of the platform
developer and not of the user, but unanticipated usage can
bring verification concerns back to the fore in particular
cases.
Verification can be divided into two sequential steps:
code verification and calculation verification. Code verification,
initially performed by the software platform developer provides
evidence that the numerical algorithms implemented in the
code are faithful representations of the underlying physical or
conceptual model of the phenomenon. Code verification should
be repeated by the user in the case of novel usage of the simulator.
Code verification establishes the reliability of the source code in
representing the conceptual model, including relevant physics,
for the problem. Ideally, benchmark problems with analytical
solutions are employed to ensure that the computer code
generates the correct solution at the specified order of accuracy.
For example, a common reference in computational fluid
dynamics (CFD) is laminar flow in a straight pipe with a circular
cross-section, whose analytical solution is well-known (Bird et al.,
1960; Stern et al., 2006). CFD modeling techniques are being
used to provide insight into flow patterns and rupture-risk of
cerebral artery aneurysms (Campo-Deaño et al., 2015; Chung and
Cebral, 2015) and for interventional radiology planning (Babiker
et al., 2013). Unfortunately, no analytic solutions are available
for most computational neuroscience applications. Therefore,
one is restricted to comparing results from one numerical
approximation to that of another, without reference to any
ground truth (Brette et al., 2007).
Next, calculation verification aims to estimate numerical
and logical errors associated with the conceptual model
implementation, i.e., the computational model representing the
target application. Going back to the laminar pipe flow example,
one would specify geometry, material properties, and loading
conditions to match the problem at hand. This typically results
in a problem that no longer has an analytical solution but
must be solved numerically. Various aspects of the numerical
representations, particularly discretization, are investigated and
refined until the model is deemed to be accurate within a
pre-specified tolerance. Upon completion of the calculation
verification step, the developer has established (and should
document) a bug-free implementation of the model concepts
with reasonable parameter values.
One of aspect of verification that is often overlooked in the
computational science community is the testing of model scripts
and binary codes. Researchers tend to focus their attention on
V&V in the context of overall program performance, but omit
testing the functionality of individual software modules. Module
verification can be implemented as a suite of tests which verify
the functionality of individual functions and modules (unit tests)
and their integration within the system (integration tests). It is
common practice to automate the testing procedures using an
automated testing framework to perform these tests after each
version update.
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Validation
Everyday vernacular often equates or confuses the terms
“verification” and “validation.” As described in the previous
section, verification seeks to ensure the quality of the
implementation of the conceptual model. Meanwhile,
validation seeks to assess how well the conceptual model
and its implementation on a specified code platform represent
the real-world system for a defined application. More rigorously
stated, validation is an assessment of the degree to which the
model and simulation is an accurate representation of the
response of the real system within the intended context of use.
In this case, validation is a comparative process that defines a
qualitative or quantitative measure of how the model differs from
an appropriate experimental or other data source – the referent,
generally a series of experiments in our context. Validation also
helps to ensure that the computational model has sufficient rigor
for the context of use, although a more rigorous or more precise
model is not necessarily more credible.
The definition of an appropriate referent is a critical aspect
of model validation. Ideally, a validation referent consists of
data obtained from a system with high similarity to the system
being modeled in an environment similar to that of the
target system. In clinical computational neuroscience, this is
often difficult since data is obtained from a rodent (not high
similarity to human), and sometimes from a slice (environment
not similar to in vivo situation). The data used should be
considered to be high quality by the model end-user community,
and should represent data not used in model development.
This separates design data from testing data (also called fit
vs. benchmark data, or calibration vs. validation data). Model
limitations due to inadequacies of the validation referent should
be communicated. Practitioners should also keep in mind that
a model validation, or the understanding of the variability of
the model in predicting real world response, is only valid in the
area of the referents used in the validation process, as illustrated
by the Validation Domain (Figure 1). The Application Domain
may be larger than the Validation Domain; it establishes the
range of input and output parameters relevant to the context
of use of the computational model. As the application of the
model deviates from the situational context described by the
referent, the influence of the model validation information will
also change.
In most cases, the more quantitative the comparison, the
stronger the case that a model and simulation is contextually
valid. Organizations such as the American Society of Mechanical
Engineers have developed standards to guide the model
practitioner in performing successful model validation activities
for specific application domains1. These comparisons range
from qualitative, graphical comparative measures to quantitative
comparative measures relying on statistical analysis of referent
and model variances, the latter obtained over a wide range of
input parameter variation (Oberkampf and Roy, 2010). Ideally,
the end-user community and regulatory agencies will play a role
in assessing the adequacy of the validation based on the context
1https://cstools.asme.org/csconnect/CommitteePages.cfm?Committee=
100108782
of an expected application and the influence the model has on
critical decision-making.
Aspects of Good Practice for Credibility
Software Aspects
The credibility of simulation results requires the reliability of
simulation protocols and software tools. Good software practices
include version control; clear, extensive documentation and
testing; use of standard (thoroughly tested) software platforms;
and use of standard algorithms for particular types of numerical
solutions. It is also desirable to rely on existing industry
standards and guidelines and to compare simulation results
against competing implementations. To maintain the highest
level of credibility, one would establish and follow these practices
at every step of the development, verification, validation, and
utilization of the simulation tools.
Version control is an approach for preserving model
development and use histories, which can also be useful for
tracing the provenance of model parameters and scope of
applicability. There exists a large number of version control
systems (VCS) which provide on-site, remote, or distributed
solutions (e.g., Git, SVN, and Mercurial). In general terms,
these systems provide tools for easy traceability of changes
in individual files, attribution of modifications and updates to
the responsible author, and versioning of specific snapshots
of the complete system. Use of a VCS is recommended for
both development (troubleshooting of bugs) as well as the
day-to-day use of the modeling tools (monitoring of modeling
progress).
Good documentation can be aided by the rigorous use of a
detailed, dated electronic laboratory notebook (e-notebook). The
e-notebook can provide automatic coordination with software
versions and data output. E-notebooks are supported through
various software packages, notably the Python Jupyter notebook
and the Emacs org-mode notebook (Schulte and Davison, 2011;
Stanisic et al., 2015; Kluyver et al., 2016). A major advantage
over the traditional paper notebook is that the e-notebook can
be directly integrated into simulation workflow, and will also
provide direct pointers to simulation code, output, figures, data,
parameter provenance, etc. This then allows later reviewers to
identify all these links unambiguously. However, compared with
a paper notebook, the e-notebook is at greater risk of falsification
due to later rewriting. This risk can be reduced by including
the e-notebook in the VCS, and can be eliminated by using
blockchain technology (Furlanello et al., 2017). An e-notebook
will also include informative records of model development and
implemented assumptions; hypotheses and approaches to testing
the hypotheses; model mark-up; detailed descriptions of the input
and output formats; and simulation testing procedures. Going
beyond the e-notebook, but also linked through it, the developer
may add case studies, verification problems, and tutorials to
ensure that other researchers and practitioners can learn to use
the model.
It should be noted that even models developed following
the aforementioned guidelines will have application bugs and
usability issues. Thus, it is valuable to also cross-verify simulation
results using alternative execution strategies and competing
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FIGURE 1 | Validation domain of a computational model for a range of input parameters and outputs (system responses). Red diamonds represent the validation set
points, where comparisons between the computational model and applicable referents were conducted by discrete simulations performed in each referent
sub-domain. The range of parameters evaluated establishes the Validation Domain (green ellipse), which will define the extent of the Application Domain (large blue
ellipse) where model performance has established credibility. Applications of the model outside of the Application Domain lack validation and have lesser credibility.
model implementations – e.g., run a simulation using BRIAN
and NEST (Cordeiro et al., unpublished) – to reduce the chance
of obtaining spurious simulation results. In addition to the
inter-model verification, simulation process should be governed
by generally applicable or discipline-specific standard operating
procedures, guidelines, and regulations.
Developing Credible Mechanism-Oriented Multiscale
Models: Procedure and Process
In science, an explanation can be inductive, proceeding from
repeated observation. Ideally, however, explanation precedes
prediction, permitting deductive reasoning (Hunt et al., 2018).
Simulation of a mechanistic multiscale model provides an explicit
way of connecting a putative explanatory mechanism to a
phenomenon of interest.
Credibility and reproducibility can be enhanced by taking note
of the many factors and workflows required to build a credible
simulation to be used in a clinical application. One of these, often
overlooked, is the role of exploratory (non-credible) simulations
in building credible simulations. We would argue that most of the
simulations that have been done in computational neuroscience
are exploratory, and that we can now begin winnowing and
consolidating these to create credible simulations for clinical
application.
Unfortunately, the problems in biology and particularly
in neuroscience are characterized by (1) imprecise, limited
measures – for example, EEG measures 6 cm of cortex at once
(Nunez and Srinivasan, 2005); (2) complex observations whose
relevance is sometimes unclear – there is no broad agreement
on the relevance of particular bands of brain oscillations
(Weiss and Mueller, 2012); (3) sparse, incommensurable and
sometimes contradictory supporting information – for example,
the difficulties of connecting microconnectomic (<1 mm; axon
tracing, dual impalement, etc.) with macroconnectomic (1 cm;
functional magnetic resonance imaging, fMRI) measures; and
(4) high degree of uncertainty – parameter values obtained
from brain slice work may differ from in vivo values. These
limitations (left of ranges in Figure 2) contrast with the more
solid information, concepts, observables and lower uncertainty
associated with “classical” engineering of man-made devices such
as computers, cars, and aircraft.
Model development is difficult, involving the need to
consider and consolidate a large variety of factors from
FIGURE 2 | Spectra to characterize biological aspects of interest. Classical
engineering problems lie at the right side of each range, working with precise
measures, strong expectations, detailed information and low uncertainty.
Unfortunately, most neuroscience problems lie far to the left with weak
measures, unclear phenomenology, sparse information and high uncertainty.
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biology, engineering, mathematics, and design under the many
constraints due to the limitations mentioned above. We have
identified a set of procedures for the building of credible
simulations, breaking out the many sub-workflows and processes
involved (Figure 3). One can spend years building tools and
running exploratory simulations that only lay the groundwork
for future credible models. Nonetheless, it is important not to
lose sight of the goal, which is to explain brain phenomenology at
one or more levels of description: electrical rhythms, movement,
behavior, cognition, etc.
The first task is to specify phenomena to be explained
(Figure 3b – Observed Phenomenon). From this perspective,
potentially relevant biological aspects are then organized
together with relevant information and data into incipient
explanations (Figure 3c – Descriptions and Explanations). In
the computational neuroscience community, there are multiple
perspectives regarding what information is to be considered
FIGURE 3 | Mechanistic multiscale modeling process. (a) Causal explanation
to be discovered. (b) Observables of phenomena to be explained. (c) Process
(workflow) to identify and organize related information into descriptions; this
process will involve simulation. (d) Meta-modeling workflows required for
defining the extent of the final model. (e) Credible simulation which matches
target phenomenon within some tolerance.
relevant. For example, some argue that dendritic morphology
and the details of ion channels are critical for understanding
cortical networks (Amunts et al., 2017), while others consider
that one need only consider simplified spiking cells (Diesmann
et al., 1999; Potjans and Diesmann, 2014; Cain et al., 2016),
and still others that it is best to work with high-level dynamical
representations of populations (Shenoy et al., 2013) or mean-field
theory (Robinson et al., 2002). Indeed all of these perspectives can
be regarded as part of the explanatory modeling that will find its
way into new concepts of (1) what is considered to be a relevant
observation or measurement (c to b in Figure 3) and (2) what will
be considered to be the form of an eventual causal explanation
(c to a). Development of this incipient explanation will involve
establishing mappings and drawing analogies between features of
the explanation and particular measurements. These mappings
and analogies may then be extended to provide working
hypotheses and to actual preliminary biomimetic simulations for
the eventual causal explanations.
A set of additional considerations (Figure 3d – Numerics and
Specifications) provide the bridge from the exploratory activities
(Figure 3c – Descriptions) to final credible models of (Figure 3e –
Software). Although illustrated toward the bottom, these aspects
of project formulation should be considered from the start as
well. In computational neuroscience, potential use cases are still
being developed and differ considerably across the four major
clinical neuroscience specialties. Use cases, and data availability,
will identify phenomena to be considered. For example, access
to electroencephalography (EEG), but not electrocorticography,
changes not only the type of software to be developed, but also the
types of explanations to be sought. Use cases will also need to be
organized based on expectations, separating near-term and long-
term needs. New computational neuroscience users, use cases,
and applications will arise in other specialties as they consider the
innervation of other organs (Barth et al., 2017; Samineni et al.,
2017; Vaseghi et al., 2017; Ross et al., 2018).
While identification of users and use cases remains
relatively underdeveloped in computational neuroscience,
the development of simulation tools is quite sophisticated. The
need for multialgorithmic as well as multiphysics simulation
has required that simulation platforms combine a variety of
numerical and conceptual techniques: ODEs, PDEs, event-
driven, graph theory, information theory, etc. Simulation
techniques have been developed over more than a half-century,
starting with the pioneering work of Hodgkin and Huxley (1952),
Fitzhugh (1961), Rall (1962), and others. Today, we have a large
variety of simulators with different strengths (Carnevale and
Hines, 2006; Brette et al., 2007; Davison et al., 2008; Goodman
and Brette, 2008; Bower and Beeman, 2012; Plesser et al., 2015;
Tikidji-Hamburyan et al., 2017) that can be used individually or
in combination, cf. MUSIC (Djurfeldt et al., 2010).
During the final stage of credible model development
(Figure 3e), we demonstrate that the model provides the desired
outputs to represent observations (e to b). A typical requirement
is that simulation outputs agree with target phenomenon
measurements within some tolerance. Since the simulation
system will be multi-attribute and multiscale, it will at the very
least begin providing mechanism-based, causal understanding
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across measures. To the extent that the model is truly biomimetic,
direct mappings will exist to specific biological counterparts –
voltages, spike times, field potential spectra, calcium levels, or
others.
Although credible software appears to be the end of the
road, actual practice will require that the resulting software
system undergoes many rounds of verification, validation,
refinement, and revision before even being released to users.
From there, continued credibility requires continuing work
on documentation, tutorials, courses, bug reports and bug
fixes, requested front-end enhancements, and identified backend
enhancements.
ROLE OF THE COMMUNITY
Community involvement is important to establish the credibility
of the modeling and simulation process, and of the models
themselves. The peer-review publication process serves as a
traditional starting point for engaging the community. However,
sharing of models, along with the data used to build and
evaluate them, provides greater opportunities for the community
to directly assess credibility. The role of sharing models and
related resources has been acknowledged in the neurosciences
community (McDougal et al., 2016a; Callahan et al., 2017).
Related resources for sharing include documentation of the
model (commonly provided in English) and implementation
encoded in its original markup or code. With access to the model
and its associated data and documentation, interested parties can
then assess the reproducibility and replicability of the models and
the simulation workflow first-hand. Further, reuse of the models
and extensions of the modeling and simulation strategies for
different applications can reveal previously unknown limitations.
These various community contributions help build up the
credibility of a model.
It is also important to note the value of cross-community
fertilization to establish a common ground for credible modeling
and simulation practices, to conform to and evolve standards
that promote a unified understanding of model quality. Such
standards enable individuals to easily exchange and reuse a
given model on its own, or in combination with other models.
Especially in multi-scale modeling, the ability to trust and build
upon existing models can accelerate the development of these
larger-scale efforts. Organizations such as the Committee on
Credible Practice for Modeling and Simulation in Healthcare
are leading efforts to establish such standards (Mulugeta and
Erdemir, 2013).
Most community involvement in computational neuroscience
has come through the establishment of databases and other
resources that have encouraged submissions from the overall
community of researchers. For example, the Scholarpedia
resource established by Izhikevich and collaborators has hosted
articles on computational neuroscience concepts and techniques
that have been used to share concepts, modeling techniques,
and information about particular modeling tools (Gewaltig
and Diesmann, 2007; Wilson, 2008; Seidenstein et al., 2015).
The Open Source Brain project provides a central location
for collaborators working on modeling the nervous system
of particular brain areas or of whole organisms, notably the
OpenWorm project for modeling the full nematode nervous
system (Szigeti et al., 2014). The Human Brain Project, an
EU effort, has established a number of “Collaboratories,” web-
accessible platforms to curate models and conduct simulations,
to encourage community involvement in coordinated projects
(Amunts et al., 2017). One of these projects aims to identify
the parameters underlying individual synaptic events recorded
in voltage clamp experiments (Lupascu et al., 2016). The Allen
Brain Institute, another large modeling and data collection center,
shares all results with the community, even before publication.
Most of the major simulator projects encourage contributions
from the community to provide either simulator extensions or
additional analytic tools. For example, the SenseLab project hosts
a SimToolDB alongside ModelDB for sharing general simulation
code (Nadkarni et al., 2002). ModelDB itself is a widely used
resource which specifically solicits model contributions and then
provides a starting point for many new modeling projects that
are extensions or ports of existing models (Peterson et al., 1996;
McDougal et al., 2016b).
The above databases are used to provide completed models
that are designed to be stand-alone but can also be used as
components of larger models. By contrast, detailed neuron
morphologies and ion channel models are generally only used as
starting points for other models to build models at higher scales.
Examples of these databases include the NeuroMorpho.Org
database of neuronal morphologies and the Channelpedia
database of voltage-sensitive ion channels (Ascoli et al., 2007;
Ranjan et al., 2011).
The availability of these valuable resources is a testament to
the successful engagement of the computational neuroscience
community. A coming challenge will be to provide mechanisms
for the discovery and selection of appropriate models for defined
contexts among the existing hundreds of models. Here again,
community involvement can play a critical role by providing the
feedback and assessments of a model and its credibility to aid
others in deciding whether to, or how to, re-use a model or part
of a model.
USE OF SIMULATION IN MEDICAL
EDUCATION
Simulation-Based Medical Education (SBME) is rapidly growing,
with applications for training medical students, and residents
(Jones et al., 2015; Yamada et al., 2017). However, the use of the
word simulation in SBME differs from our usage above. SBME is
referring to simulated reality: paper exercises based on protocols;
mannequins; re-enactments with live actors for physical exams or
major disasters; detailed computer-based virtual reality training,
similar to video games. Currently, even the most advanced
mannequins and computer-generated simulations have very
limited capacity to produce a realistic focal neurological deficit or
combination of signs and symptoms. Design and implementation
of SBME tools is especially challenging in brain disease due to
the complexity of the brain, and the variety of its responses to
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insult (Chitkara et al., 2013; Ermak et al., 2013; Fuerch et al., 2015;
Micieli et al., 2015; Konakondla et al., 2017). This complexity
suggests that back-end multiscale modeling would be particularly
valuable in SBME development for brain disease.
Mechanistic multi-scale modeling has been used in
both pre-clinical and clinical education to explain disease
causality. For example, a demyelination simulation, relevant
to multiple sclerosis and Guillain-Barre syndrome, is available
that demonstrates both the effects of demyelination on
action potential propagation and the consequent increase in
temperature sensitivity (Moore and Stuart, 2011). Although
this model has not been linked directly to a hands-on SBME
activity, it could be linked to a training activity for Nerve
Conduction Studies. Another promising area of recent
research interest is in the area of neurorobotics, where
robotic arms have been linked to realistic biomimetic
simulations in the context of neuroprosthetics (Dura-
Bernal et al., 2014; Falotico et al., 2017). In the clinical
neurosciences, epilepsy is one of the most successfully
modeled disorders in neurology and neurosurgery (Lytton,
2008). Jirsa et al. (2017) have pioneered models of individual
patients prior to epilepsy surgery – see Section “Personalized
Medicine Simulation for Epilepsy.”. These simulations could
now be extended into training protocols for neurology
and neurosurgery residents, offering an opportunity
for melding educational simulation with computational
neuroscience.
Current SBME efforts are focused on mannequins. A generic
mannequin was used to train medical students to manage
differential diagnoses and emergency procedures for status
epilepticus and acute stroke (Ermak et al., 2013). The mannequin
used was not capable of mimicking visible, or electrographic,
signs of stroke or seizures. Instead, students were given chart data
and simulation actors playing family member. Such simulations
necessarily fall short on one aspect of effective implementation of
SBME (Issenberg et al., 2005): the degree to which the simulation
has a “real-life” feel.
In the future, life-like and highly immersive SBME will
facilitate the learning of dangerous medical procedures, including
emergencies and recovery from mistakes, in the way that is
currently done with simulators used to train pilots, astronauts
and flight controllers. Ideally, neurology and neurosurgery
(and eventually psychiatry and physiatry) SBME systems will
produce learned skills that are transferable to patient care. The
predictive validity of the simulation could then be assessed by
comparing performance measured under simulation conditions
with corresponding measurements made on real patients
(Konakondla et al., 2017). However, the skill level of a learner
in the simulator should not be taken as a direct indication of
real-life skill performance. In one example from flight training,
a particular technique (full rudder), which served to “game” the
simulator, resulted in a fatal accident due to tail separation when
used in real life (Wrigley, 2013).
An example of SBME in neurosurgical training is the Neuro-
Touch surgical training system developed by the National
Research Council of Canada (Konakondla et al., 2017). The
systems is built around a stereoscope with bimanual procedure
tools that provide haptic feedback and a real-time computer-
generated virtual tissue that responds to manipulation. As the
surgeon is working through a surgical scenario, the simulator
records metrics for detailed analysis to develop benchmarks for
practitioners at different stages of training.
The Neurological Exam Rehearsal Virtual Environment
(NERVE) virtual-patient SBME tool was developed to teach
1st- and 2nd-year medical students how to diagnose cranial
nerve deficits (Reyes, 2016). Educational results were validated
using questionnaires designed for virtual patient simulators
(Huwendiek et al., 2014). An interesting future extension would
be to provide an underlying simulator that would take account
of the many complex neurological deficits found in patients due
to the anatomical confluence of tracts in the brainstem. Such a
simulator would be useful for neurology residents as well as for
medical students.
To advance both the technologies and methodologies applied
in SBME, the Society for Simulation in Healthcare (SSH)
recently established the Healthcare Systems Modeling and
Simulation Affinity Group. The Committee on Credible Practice
of Modeling and Simulation in Healthcare (Mulugeta and
Erdemir, 2013) has been collaborating with the SSH community
by providing guidance on how to design and implement
explicit multiscale computational models into traditional SBME
systems. Additionally, the Congress of Neurological Surgeons
has formed a Simulation Committee to create simulations
for resident education (Konakondla et al., 2017). The US
Food and Drug Administration (FDA) and the Association for
the Study of Medical Education have also been working to
publish standards and guidelines for regulatory submissions
involving computational models and simulations for healthcare
applications (Hariharan et al., 2017).
USE OF MODELING IN CLINICAL
DOMAINS OF BRAIN DISEASE
Simulations in the clinical neuroscience domain have largely
focused on accounting for the neural activity patterns underlying
brain disease. Testing the predictions arising from the simulation
is dependent on technological advances in neuromodulation,
pharmacology, electrical stimulation, optogenetic stimulation,
etc. Neuropharmacological treatment is systemic, with effects
wherever receptors are found, often peripherally as well as
centrally. Although targeted treatment with an implanted
cannula is possible, it is not widely used clinically. By contrast,
electrical stimulation can be highly targeted with a local
placement of electrodes. Development of closed-loop systems
and devices for brain stimulation (Dura-Bernal et al., 2015),
are currently being used and show promise in treating a wide
range of neurological diseases and disorders including Parkinson,
depression, and other disorders (Johansen-Berg et al., 2008; Shils
et al., 2008; Choi et al., 2015). Non-targeted electrostimulation
using transcranial electrodes is also being widely used but
remains controversial, and lacks precise clinical indications
(Lefaucheur et al., 2014; Esmaeilpour et al., 2017; Huang et al.,
2017; Lafon et al., 2017; Santos et al., 2017). Consideration is also
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being given to future use of optogenetic stimulation therapies
that would offer still greater precision compared to electrical
stimulation – targeting not only a particular area but a particular
cell type or set of cell types within that area (Vierling-Claassen
et al., 2010; Kerr et al., 2014; Samineni et al., 2017). All such
stimulation protocols require identification of suitable, if not
necessarily optimal, ranges of parameters, e.g., strength, duration,
frequency, waveform, location, iterations, schedule, reference
activity, etc. It is not generally feasible to evaluate this large and
high-dimensional stimulus parameter space empirically through
experimentation. Hence, stimulation development would benefit
from the extensive explorations possible using simulation of the
response of micro- and macro-scale neural circuits in the brain,
potentially in patient-specific fashion.
Successful application of models in the clinical domain
will in future depend on the use of credible practices to
develop, evaluate, document and disseminate models and
simulations, using the principles outlined above. Nonetheless,
clinical applications will also always need to be verified and
validated by in a clinical before being utilized. At present, studies
have been done in the absence of standards for computational
neuroscience models. The current manuscript is designed in
part to continue the discussion about the development of
such standards. Meanwhile, clinically relevant studies have been
performed with varying degrees of adherence to engineering
best-practices. Here, we briefly discuss two such studies, noting
adherence to such practices and where investigators may have
fallen short.
Simulation of Multi-Target Pharmacology
We first consider a mechanistic multiscale model of multi-
target pharmacotherapy for disorders of cortical hyperexcitability
(Neymotin et al., 2016). The study assessed hyperexcitability in
an exploratory manner. They did not identify a single clinical
context. Rather, they left the study open for exploration of cortical
activation in both dystonia and seizures.
The multiscale model included molecular, cellular, and
network scales, containing 1715 compartmental model neurons
with multiple ion channels and intracellular molecular dynamics.
Data used to develop the model was taken from a large number of
sources including different species, different preparations (slice,
cell culture, in vivo, ex vivo), different age animals, different
states, different conditions. None of the data was taken from
the clinical disorders in question due to limitations of human
experimentation. As the model lacked a description of the motor
output, the simulations could not be systematically evaluated
in the context of dystonia. Beta activation in the cortex was
used as a surrogate biomarker to evaluate whether simulations
could account for activity patterns relevant to dystonia. However,
as with many brain diseases, there is no established, clinically
validated biomarker for dystonia. Additionally, the model
lacked representations of spinal cord or limb, as well as many
pharmacological parameters, particularly with respect to the role
of neuromodulators (known unknown), brain states (less known
unknown) and metabolic parameters.
The simulations were able to reproduce the target patterns
of heightened cortical activity. The corresponding pathological
parameter sets were identified by independent random variations
in parameters. These simulations demonstrated degeneracy,
meaning that there were many combinations of parameters that
yielded the pathological syndrome. The primary result was that
no individual parameter alteration could consistently distinguish
between pathological and physiological dynamics. A support
vector machine (SVM), a machine learning approach, separated
the physiological from pathological patterns in different regions
of high-dimensional space, suggesting multi-target routes from
dystonic to physiological dynamics. This suggested the potential
need for a multi-target drug-cocktail approach to intervening in
dystonia.
Several aspects of best-practices were utilized in this study.
Dissemination: The model was disseminated via publication
and meeting presentations with the code made available via
ModelDB resource (reference #189154). Documentation: Limited
documentation was also made available at a level conforming
to ModelDB requirements, consistent with practices accepted by
the computational neuroscience community. Provenance: Due
to the nature of the clinical domain, parameter provenance
was partial; details of parameter sources were included in the
paper. Replicability: Model replicability was tested by ModelDB
curators, but was not tested directly by the manuscript reviewers.
Reproducibility: There have not yet been any third-party studies
reproducing the model. There are unexploited opportunities
to compare the model with alternative implementations, for
example by considering simpler modeling formalisms for single-
neuron activity. The credibility of the simulations along with
insights derived from the results would be enhanced by
follow-on work that reproduces the simulations using similar
or alternative implementations. Validation: The current lack
of an adequate biomarker for dystonia limits the ability to
validate this study in the future. Verification: The NEURON
simulation platform was used in this study. It has been
vetted both internally and in comparison to other simulators
(Brette et al., 2007). Versioning: The Mercurial VCS was used
to track parameter variations and match to corresponding
simulations.
Personalized Medicine Simulation for
Epilepsy
As a contrast to above examination of the credibility practices
as applicable to a mechanistic multiscale model, we considered
these issues in the context an individualized phenomenological
model of seizure propagation by Proix et al. (2017), implemented
using The Virtual Brain platform (Sanz-Leon et al., 2013). The
study was aimed at demonstrating that patient-specific virtual
brain models derived based on information from diffusion
MRI technique have sufficient predictive power to improve
diagnosis and surgery outcome in cases of drug-resistant
epilepsy. Data from individual patient tractography and EEG
was utilized to parameterize each individual model separately.
The diffusion MRI-based connectivity observed between the
parcellated brain regions in each individual was used to
create patient-specific connectivity matrices that related distinct
autonomous oscillators (“Epileptors”) at each brain region. The
resultant patient-specific virtual brain model was evaluated for
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its consistency in predicting seizure-like activity patterns in that
patient.
Dissemination: The model and the results were disseminated
as part of the published manuscript as well as through
conference presentations and posters. Documentation: The
platform is well documented. Internal documentation of
individual models for use by neurosurgeons may be available
but was not publically available, perhaps for reasons of patient
confidentiality. Provenance: Provenance of connectivity data
from individual patients was made clear. The Epileptor model
is a phenomenological description of oscillatory patterns of
activity in a bulk tissue (neural mass model); hence, there
are no explicit parameters or variables that directly arise from
specific molecular, cellular and metabolic pathways. Replicability:
While the manuscript was peer-reviewed, it is not readily
apparent if the model was tested directly in simulations by the
manuscript reviewers. Reproducibility: Virtual Brain provides
a particular dynamical formalism based on bulk activity. It
would be interesting to see if alternative model formalisms
that incorporate details at cellular scales would produce
similar results. Validation: Alternative connectivity matrices
and weightings were considered based on data from control
subjects, shuﬄing the data, changing the weights while preserving
the topology of the connectivity, and log-transformation. The
authors demonstrated that prediction of seizure patterns was best
when the patient-specific topology of the connectivity matrix
was utilized. Verification: The study considered alternative
models based on fast coupling, no time-scale separation, and
a generic model that shows saddle-node bifurcation. Based on
the simulations considering these alternative models, the authors
concluded that weak coupling is necessary for the predictions
on the recruited networks. The Virtual Brain platform has
undergone considerable code testing over the years. Versioning:
The platform is made available in a public repository using Git.
ACTIONABLE RECOMMENDATIONS
AND CONCLUSIONS
The potential of modeling and simulation in clinical application
and medical education are promising. However, this potential
is mainly being tapped in the areas that are close to traditional
engineering domains, such as CFD and stress analysis. For
this reason areas of medicine that are related to blood flow,
biomechanics and orthopedics have benefited most. By contrast,
the brain has an idiosyncratic evolved set of mechanisms that
are extremely difficult to reverse engineer and which draw on
many areas of engineering, some of which have not been invented
yet. Therefore, computational neuroscience remains primarily
in the research domain, with only fragmented translations
from computational neuroscience to clinical use or to medical
education. As medical practice moves toward precision, and then
personalized, healthcare, multiscale modeling will be necessary
for simulating the individual patient’s response to disease and
treatment. To move toward this goal, we must cultivate credible
modeling and simulation practices taken from traditional areas of
engineering.
Model Configuration Management
Since many models will be built within the context of a simulation
platform, we refer here to “Model configuration.” However, all of
these points apply a fortiori to models being built from scratch in
a general-purpose programming language.
(1) Use version control: Git or Mercurial (hg) are preferred.
GitHub can be used to host projects (Dabbish et al.,
2012). In shared projects, version control establishes who
is responsible for which pieces of code.
(2) Use an electronic notebook (e-notebook) with clear
documentation of every stage of model development
(including mistakes).
(3) Include provenance of parameters in e-notebook and via
version control – parameters may be changed due to new
experimental data, and it is valuable to have a clear record
of when and why the change was made and what the
consequence was for the model.
(4) Perform testing of model components: for example,
demonstrate that the cell-types show proper firing
characteristics before incorporating them into networks.
(5) Later in the process, develop a test suite for further testing.
Ideally, model testing should be performed at every version
update. A test suite can be linked to standard testing
frameworks to automate this testing. Commonly used
frameworks include Travis CI (Continuous Integration),
Circle CI, Jenkins, and AppVeyor.
(6) Whenever possible, use reliable model development
platforms such as NEST, BRIAN, NEURON, MOOSE,
NENGO, PyNN, etc. This will increase the likelihood of
accurate simulation and will enhance sharing. Similarly,
model components should be taken from reliable databases
of morphologies, channels and other components.
(7) Later in the process, encourage other groups to compare
simulation results on alternative platforms or with different
implementations.
Verify and Validate Models
(1) Simulation platform developers generally verify the
adequacy of the numerical analysis. Some simulators offer
alternative numerical solvers which can be tested to assess
the qualitative similarity of results. For example, one
problematic area is the handling of fixed and variable time
steps for spike handling in networks (Lytton and Hines,
2005).
(2) Verify algorithms you develop. For example, when
developing a neuronal network, make sure that the network
design is correct before moving to actual simulation.
(3) Verify that the simulation is a reasonable implementation
of the conceptual model, ideally by comparing a graphical
output of basic phenomenology with target phenomena. It
is tragically easy to move on to the analysis phase of the
study without first looking at the raw output to make sure it
is reasonable.
(4) Validate based on data from a real-world system. In some
cases, it may be important to distinguish simulation results
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from the same model for different situations, e.g., in vitro
slice vs. in vivo background activation.
(5) Test robustness of a model to parameter changes to
ascertain whether a particular result is only seen with a
particular set of parameter choices.
(6) Document and propagate V&V testing processes and
findings to the community.
Although all of these steps are valuable, it is important to
understand that higher model fidelity and V&V rigor do not
automatically translate to higher credibility.
Share Models and Data
(1) Submit models to shared databases such as ModelDB or via
GitHub. Share widely – you can submit the same model to
various databases, and submit components such as cells and
ion channel definitions to component databases.
(2) Document thoroughly – the Methods section of a paper
will provide an overall gloss but, typically, will not provide
sufficient detail about software design and use. Comment
code. Provide a README on how to launch the simulation.
(3) Disseminate – publish, of course, and present posters and
talks to various audiences. In a multidisciplinary area such
as computational neuroscience, the same model will say
different things to different audiences – physiologists,
anatomists, cognitive neuroscientists, neurologists,
psychiatrists, other modelers.
(4) Join communities via organizations such as Society
for Neuroscience (SFN), Computational and Systems
Neuroscience (CoSyne), Organization for Computational
Neuroscience (CNS).
(5) Obtain independent reviews of models. This is difficult
and time-consuming but some grants are now providing
funding explicitly to pay for consultants to review models
(NIH, 2015).
Define Context of Use and Simulation
Requirements
We distinguished above between exploratory models, done
by an individual researcher in order to provide ideas and
new hypotheses, and context models, purpose-built models for
external users in a given environment, for example, clinical or
medical education use. In the latter case, it is essential to be
clear about who the users are and which usage patterns (sets
of use cases) are to be targeted and which ones are to be
excluded or to be left as part of longer-term goals. However,
even exploratory models can benefit from these considerations,
envisioning yourself, your team, and perhaps an experimental
collaborator as users.
(1) Identify the users. Even if you are the only user at the
beginning of the project, you will be sharing the model later,
so you may want to take account of other users who are
not as familiar with your domain. For clinical use, a clinical
assistant for epilepsy would be different for neurosurgeons
vs. neurologists.
(2) Identify the context of use. For example, will this model
primarily be used to study dynamics, or will it be extended
into information theory or will it be expected to perform a
memory function, etc.
(3) Identify intended uses. You may have one intended use
for yourself as a modeler to generate new theoretical
hypotheses and another for your experimental colleague.
In the context of an educational application, an SBME for
medical students will be very different than an application
for residents or continuing medical education.
(4) Attempt to identify usage patterns – it is often the case
that underprepared users who have not read the manual
use a program in unintended, and sometimes dangerous,
ways. Platforms and programs can produce warnings
when it detects that the user is trying to use unsuitable
combinations of parameters, etc.
Translation of Computational
Neuroscience Models for Clinical and
Medical Education Use
In the preceding sections, we have given examples of particular
clinical and educational/training scenarios that may be ripe for
the introduction of simulation technology. Here we list both
those already mentioned and others that have potential for future
applications. This list is by no means complete.
(1) Education: Integration of modeling into mannequins and
online virtual patients to reproduce neurological deficits
in SBME. Initial versions of this would not require
mechanistic multiscale modeling but could be done
with phenomenological modeling. Future versions would
incorporate mechanistic modeling to also incorporate the
time-course of signs and symptoms (dynamics at multiple
timescales).
(2) Training: Virtual reality simulators with haptic feedback for
neurosurgery training.
(3) Personalized patient simulations to decide on surgery vs.
interventional radiology (coiling) for aneurysms.
(4) Clinical decision making: Personalized patient simulations
to decide on surgical approach for epilepsy surgery (Jirsa
et al., 2017).
(5) Simulation for seizure prediction in Epilepsy Monitoring
Unit (EMU).
(6) Personalized patient simulation to determine therapies for
Parkinson disease to include combinations of surgical,
electrical and pharmacological therapy (Grill and McIntyre,
2001; Hammond et al., 2007; Shils et al., 2008; Van Albada
et al., 2009; Kerr et al., 2013; Holt and Netoff, 2017).
(7) Head, brain and neural modeling for understanding
effects of different kinds of electrical stimulation including
transcranial stimulation (Esmaeilpour et al., 2017; Huang
et al., 2017; Lafon et al., 2017).
(8) Modeling vagal and peripheral nerve stimulation for
treatment of systemic disorders (NIH SPARC program2).
2https://commonfund.nih.gov/sparc
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(9) Psychiatry: identifying the varying roles of disorder in
dopaminergic, glutamatergic, inhibitory and other deficits
in schizophrenia to develop new multi-target therapies
(Lisman et al., 2010).
(10) Neurorehabilitation (physiatry) Modeling the interface
between neural and musculoskeletal models to
treat spasticity or dystonia (van der Krogt et al.,
2016).
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